Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

37.30$ -0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Novo Nordisk A/S (NVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 78,488 million DKK. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of DKK.

Tick rows to compare them in a chart (up to 4)

Income Statement NVO
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	58,731	65,863	65,349	68,060	71,311	85,683	78,087	76,857	74,976	79,144	96,823	78,488	329,431
Cost of Revenue	9,713	10,014	9,916	10,274	11,308	13,024	12,890	12,846	17,904	15,148	13,598	17,100	63,750
Gross Profit	49,018	55,849	55,433	57,786	60,003	72,659	65,197	64,011	57,072	63,996	83,225	61,388	265,681
Research & Development	8,128	10,460	8,606	16,166	9,488	13,802	10,308	11,690	15,393	14,648	10,284	17,787	58,112
Selling, General & Administrative	1,256	1,456	1,157	1,157	1,382	1,580	1,220	1,316	1,884	1,549	1,140	1,309	5,882
Total Operating Expenses	22,105	29,083	23,587	31,852	26,181	35,922	26,406	30,562	33,390	32,260	23,607	34,327	123,584
Operating Income	26,913	26,766	31,846	25,934	33,822	36,737	38,791	33,449	23,682	31,736	59,618	27,061	142,097
Interest Expense	2,168	916	2,074	1,562	821	5,093	5,183	4,958	5,007	8,630	3,499	1,500	18,636
Pre-Tax Income	28,063	27,620	31,918	25,332	34,384	35,557	37,033	33,805	25,517	34,185	62,172	26,875	148,749
Income Tax Expense	5,585	5,657	6,511	5,282	7,083	7,327	7,999	7,302	5,511	7,294	13,615	5,886	32,306
Net Income	22,478	21,963	25,407	20,050	27,301	28,230	29,034	26,503	20,006	26,891	48,557	20,989	116,443
EBITDA	32,756	28,511	36,906	35,739	37,355	45,848	46,046	43,596	33,274	39,747	69,207	38,679	180,907

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings